F.Jr.KengT.DeangeloJ.et al
BPC 157 as a Therapy for Retinal Ischemia Induced by Retrobulbar Application of L-NAME in Rats
Reported side effects (minimal) Most users report zero side effects - Epithalon remarkably well-tolerated Occasional reported effects: Mild injection site reactions (redness, slight swelling) Temporary headache (first 1-2 days) Slight drowsiness initially (adjusting to improved sleep ) Vivid dreams (from enhanced melatonin ) Increased appetite in some (rare) What Epithalon does NOT typically cause: No nausea (unlike GLP-1 agonists ) No GI upset No hormonal disruption No mood changes (may improve mood) No dependency or withdrawal Side effect comparison: Managing minor side effects: Headache: Hydrate well, usually resolves day 2-3 Drowsiness: Inject at bedtime instead of morning Vivid dreams: Enjoy them or reduce dose slightly Injection reactions : Rotate sites, ice after injection See our peptide safety and risks guide and common peptide mistakes to avoid
It is fully synthesised in the laboratory, not extracted
A common recommendation is 3-5 IV sessions spread over 2 to 3 weeks for new patients, though that may be overkill for most people
Whether its slow recovery, chronic inflammation, or unexplained fatigue, the goal is to trace it back to a measurable disruption something we can map, track, and correct with precision